Immunohistochemical study for peripherin in association with anti-MBP and anti-NF-H antibodies showed a markedly increased expression of peripherin and NF-H in the proband compared to a CMT2A patient (MFN2R94W, axonal neuropathy control) and a healthy control (Figure 3A). The gene discussed is MBP; the disease is axonal neuropathy.